FDA Revokes Emergency Authorization For Hydroxychloroquine To Treat COVID-19
Published
The Food and Drug Administration revoked its emergency authorization for hydroxychloroquine as an alternative treatment for coronavirus amid safety concerns. In March, FDA had given emergency use authorization for two malaria drugs - chloroquine and hydroxychloroquine - for the treatment of hospitalized severe COVID-19 patients. The US federal agency said in a statement that clinical trials hav
Full Article